Skip to main content
    D

    Doximity Inc (DOCS)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NYSE

    $32.79
    -0.55 (-1.65%)

    Market Cap: $5.95B

    Last updated: Nov 17, 2026 at 11:03 AM ET

    Doximity Inc (DOCS) Financials: Revenue, Profit and Cash Flow

    Updated Nov 5, 2026. Financial statements from company filings, amounts in US dollars.

    Doximity reported revenue of $644.86M for the fiscal year ended Mar 31, 2026, up 13.1% from the year before. That year, net income was $196.05M with a net margin of 30.4%, operating cash flow was $326.46M and free cash flow was $317.56M. The quarter ended Sep 30, 2026 had revenue of $174.54M and net income of $34.73M.

    Revenue and Margins

    The operating margin was 33.3% in the fiscal year ended Mar 2026. Over the 7 years to Mar 2026, revenue grew from $85.69M, a compound annual rate of 33.4%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Mar 2026$644.86M+13.1%89.1%33.3%30.4%
    Mar 2025$570.40M+20.0%90.2%39.9%39.1%
    Mar 2024$475.42M+13.5%89.3%34.5%31.0%
    Mar 2023$419.05M+22.0%87.2%29.9%26.9%
    Mar 2022$343.55M+66.0%88.4%33.0%45.1%
    Mar 2021$206.90M+77.8%84.9%25.8%24.3%
    Mar 2020$116.39M+35.8%87.2%19.0%25.5%
    Mar 2019$85.69MN/A87.3%8.1%9.1%
    Annual, fiscal years ended Mar 2019 to Mar 2026

    Income Statement

    In the fiscal year ended Mar 2026, net income fell 12.2% from the year before. In the quarter ended Sep 2026, net income fell 44.0% from the same quarter a year earlier.

    Annual

    Line itemMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
    Revenue$644.86M$570.40M$475.42M$419.05M$343.55M$206.90M$116.39M$85.69M
    Cost of revenue$70.33M$55.87M$50.67M$53.49M$39.79M$31.20M$14.90M$10.89M
    Gross profit$574.54M$514.52M$424.75M$365.56M$303.76M$175.70M$101.49M$74.81M
    Research and development$130.70M$93.04M$81.98M$80.19M$62.35M$43.87M$32.44M$27.50M
    Operating income$214.92M$227.80M$163.88M$125.11M$113.54M$53.30M$22.16M$6.92M
    Net income$196.05M$223.19M$147.58M$112.82M$154.78M$50.21M$29.74M$7.83M
    EBITDA$235.20M$236.77M$177.78M$155.34M$133.13M$68.55M$29.04M$7.47M
    Fiscal years ended Mar 2019 to Mar 2026

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$174.54M$156.62M$145.37M$185.05M$168.53M$145.91M$138.29M$168.60M$136.83M$126.68M$118.06M$135.28M
    Gross profit$149.19M$132.93M$125.97M$166.35M$152.10M$130.12M$123.82M$154.42M$123.16M$113.13M$105.49M$123.09M
    Operating income$43.92M$33.64M$24.83M$71.90M$63.68M$54.52M$48.68M$79.92M$53.14M$46.05M$41.85M$58.55M
    Net income$34.73M$24.32M$19.11M$61.56M$62.06M$53.32M$62.46M$75.20M$44.15M$41.38M$40.62M$47.96M
    Last 12 quarters

    Balance Sheet

    As of Mar 2026, cash and equivalents exceeded short-term debt of $2.11M by $217.07M.

    Annual

    Line itemMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
    Total assets$1.12B$1.26B$1.08B$1.14B$991.36M$251.72M$138.92M$86.56M
    Current assets$944.26M$1.09B$912.94M$975.45M$904.14M$209.40M$122.97M$83.36M
    Cash and equivalents$219.18M$209.61M$96.78M$158.03M$112.81M$66.39M$48.43M$33.61M
    Total liabilities$172.85M$181.68M$177.98M$170.77M$112.76M$103.52M$137.78M$37.81M
    Short-term debt$2.11M$2.21M$2.15M$1.75M$642.00K$970.00K$1.96MN/A
    Shareholder equity$950.84M$1.08B$901.40M$966.12M$878.59M$66.74M$1.14M$48.50M
    Fiscal years ended Mar 2019 to Mar 2026

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$1.09B$1.08B$1.12B$1.16B$1.26B$1.20B$1.26B$1.17B$1.12B$1.07B$1.08B$1.00B
    Total liabilities$163.29M$167.78M$172.85M$177.73M$161.58M$178.85M$181.68M$141.04M$157.32M$159.88M$177.98M$136.03M
    Cash and equivalents$218.61M$273.60M$219.18M$64.84M$169.25M$137.26M$209.61M$165.27M$184.25M$111.44M$96.78M$123.09M
    Shareholder equity$928.48M$916.07M$950.84M$979.30M$1.10B$1.03B$1.08B$1.03B$961.20M$913.58M$901.40M$864.61M
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Mar 2026, free cash flow was 97.3% of operating cash flow. Share repurchases came to 135.9% of it.

    Annual

    Line itemMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
    Operating cash flow$326.46M$273.26M$184.10M$179.60M$126.58M$82.97M$26.20M$15.31M
    Capital expenditures$8.90M$6.53M$5.80M$6.18M$5.70M$4.61M$4.24M$1.19M
    Free cash flow$317.56M$266.74M$178.29M$173.42M$120.88M$78.36M$21.95M$14.12M
    Share repurchases$431.65M$120.29M$280.72M$85.32M$6.68M$3.49M$0N/A
    Investing cash flow$147.17M-$29.30M$31.19M-$59.92M-$640.57M-$70.42M-$13.10M-$9.07M
    Financing cash flow-$464.06M-$131.14M-$276.52M-$74.46M$560.41M$5.41M$1.72M$985.00K
    Fiscal years ended Mar 2019 to Mar 2026

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow$93.28M$41.99M$109.52M$60.89M$93.94M$62.10M$98.49M$65.19M$68.35M$41.24M$63.94M$50.05M
    Capital expenditures$1.95M$2.38M$2.25M$2.31M$2.37M$1.97M$1.51M$1.77M$1.54M$1.70M$1.63M$1.32M
    Free cash flow$91.33M$39.60M$107.27M$58.58M$91.58M$60.13M$96.98M$63.42M$66.80M$39.54M$62.31M$48.73M
    Last 12 quarters

    Frequently Asked Questions About DOCS

    What is Doximity's annual revenue?

    Doximity reported revenue of $644.86M for the fiscal year ended Mar 31, 2026.

    How fast is Doximity's revenue growing?

    Revenue was up 13.1% for the fiscal year ended Mar 31, 2026 compared with the year before. The compound annual revenue growth rate over 3 years was 15.5%.

    Is Doximity profitable?

    Yes. Doximity reported net income of $196.05M for the fiscal year ended Mar 31, 2026, with a net margin of 30.4%.

    How much free cash flow does DOCS generate?

    For the fiscal year ended Mar 31, 2026, operating cash flow of $326.46M minus capital expenditures of $8.90M produced free cash flow of $317.56M.

    How much debt does Doximity have?

    The balance sheet dated Mar 31, 2026 reported short-term debt of $2.11M and cash and equivalents of $219.18M.